EGL Engility Holdings, Inc.

   By Josh Beckerman 
 

NeoGenomics Inc. (NEO) shares rose 8.4% to $14.25 as S&P Dow Jones Indices said the genetic testing company will join the S&P SmallCap 600.

NeoGenomics will join the index before trading opens on Jan. 14, replacing government-services provider Engility Holdings Inc. (EGL). In September, Science Applications International Corp. (SAIC) agreed to buy Engility in a stock deal originally valued at $1.5 billion.

Last week, Needham & Co. initiated coverage of NeoGenomics with a Buy rating and a $14 price target.

Write to Josh Beckerman at josh.beckerman@wsj.com

(END) Dow Jones Newswires

January 08, 2019 20:01 ET (01:01 GMT)

Engility Holdings, Inc. (NYSE:EGL)
Historical Stock Chart
From May 2024 to Jun 2024

Engility Holdings, Inc. (NYSE:EGL)
Historical Stock Chart
From Jun 2023 to Jun 2024